Clozapine levels and caffeine.
Odom-White
A
A
de Leon
J
J
D000328:Adult; D002110:Caffeine / Q000378:metabolism* / Q000494:pharmacology; D003024:Clozapine / Q000031:analogs & derivatives / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D019388:Cytochrome P-450 CYP1A2; D019389:Cytochrome P-450 CYP2D6; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005260:Female; D006801:Humans; D006899:Mixed Function Oxygenases / Q000378:metabolism; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy*
D065607:Cytochrome P-450 Enzyme Inhibitors; C058272:norclozapine; D002110:Caffeine; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; C104464:CYP3A protein, human; D019388:Cytochrome P-450 CYP1A2; D019389:Cytochrome P-450 CYP2D6; D051544:Cytochrome P-450 CYP3A; D003024:Clozapine